Skip to Main Content

Paper Details

Tumoral and immune heterogeneity in an anti-PD-1-responsive glioblastoma: a case study.
Cold Spring Harb Mol Case Stud
5
2020
EGFR, GBM, IDH, MGMT, PD-1, RNA, T-cell, anti-, anti-PD-1, glioblastoma, patient, primary tumor, tumor, whole
Author NameAffiliation
Nadejda M Tsankovaand Icahn School of Medicine at Mount Sinai
Kambiz NaelIcahn School of Medicine at Mount Sinai
Robert SebraIcahn School of Medicine at Mount Sinai
Robert Sebra
Robert SebraIcahn School of Medicine at Mount Sinai
Robert Sebra
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Bojan LosicIcahn School of Medicine at Mount Sinai
Bojan LosicTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Bojan LosicObesity and Metabolism Institute, and Icahn School of Medicine at Mount Sinai
Bojan LosicIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
  • 1 - 16

Datasets

Release 1.2